An important note: In August 2025, the Trump Administration said it is considering a pilot program that would cover weight-loss drugs under Medicare for five years
Bahit MC, Gibson CM, Kuleta M, Szarpak , Malinowski KP, Kowalska-Bobko I, et al
An expected surge in generic GLP-1s is anticipated to reshape not only pharmaceutical pricing and access but also the global MedTech ecosystem supporting drug delivery
GLP-1s Reduce Inflammation Traditional cardiology frames heart disease as a plumbing problem arteries slowly clog until fully blocked which is why a standard lipid panel focuses almost entirely on cholesterol
Beginning in 2022, the FDA allowed compounding pharmacies to produce compounded versions of GLP-1 medications, says Dr
How long does it take to see improvements in blood sugar control after starting semaglutide